T he American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR) collaborate annually to assess the status of cancer in the United States (U.S.). The 1998 report documented the first sustained decline in cancer death rates since the 1930s. Subsequent reports updated information on trends in incidence and death rates and featured timely topics. [1] [2] [3] [4] [5] [6] [7] [8] This report continues the annual update tradition and presents a special section on cancer among U.S. Hispanic/Latino populations, a large and diverse ethnic group whose cancer experience has not been well described until recently 9, 10 as concerns about misclassification and cultural and other differences among various Latino groups and limited population data have restricted national analyses. Although challenges remain, a comprehensive compilation of cancer information for the estimated 39.9 million U.S. Latinos in 2003 is relevant to future directions in cancer control strategies. 11 
MATERIALS AND METHODS
Data Sources for Cancer Cases and Deaths U.S. state and regional population-based cancer registries collect information on new cancer diagnoses. They participate in the NCI's Surveillance, Epidemiology, and End Results (SEER) Program, the CDC's National Program of Cancer Registries (NPCR), or both. All cancer registries are members of NAACCR. Incidence data refer to invasive cancers, excluding in situ, with the exception of bladder. Primary cancer site and histology data were coded according to the International Classification of Diseases for Oncology (ICD-O) edition in use at the time of diagnosis, converted to the Third Edition, 12 and categorized according to SEER site groups (To maximize comparability between ICD-O-2 and ICD-O-3, borderline tumors of the ovary, refractory anemias, and other myelodysplastic syndromes were excluded, and pilocytic astrocytomas were included.). 13 For persons aged 0-19 years, cancer data were categorized using the International Classification of Childhood Cancer (ICCC) based on ICD-O-3. 12, 14 Statistics for men and women include persons of all ages; childhood cancers include persons aged 0-14 years, and adolescents aged 15-19 years.
U.S. cancer deaths, reported to state vital statistics offices and consolidated through the CDC's National Vital Statistics System, 15 were coded using the version of the International Classification of Diseases (ICD) in use at the time of death. [16] [17] [18] [19] Underlying causes of cancer death for the total U.S. were grouped for maximum comparability among ICD versions. 13 Mortality data are provided by all 50 states and the District of Columbia; however, death rates for Hispanics from 5 states (Maine, Minnesota, New Hampshire, North Dakota, and Oklahoma) were excluded because of incomplete ethnicity information for at least one of the reporting years in the report. 20 All analyses (long-term trends, fixed interval trends, and average annual rates) were based on national mortality data and varying geographic areas for incidence because incidence data are not uniformly available for all population groups, time periods, and geographic areas. (We examined data for 22 sites for incidence and 21 for cancer deaths to accommodate the top 15 cancers in each racial and ethnic population. Kaposi Sarcoma and mesothelioma were only reported as cause of death beginning in 1999 and therefore not reported separately for mortality.) Long-term (1975 Long-term ( -2003 trends for all races combined by sex for all-sites combined and the 15 most common cancers were based on SEER incidence data covering about 10% of the U.S. population, the only source for long-term incidence analyses. 21 Fixed-interval trends (1995 through 2003) for 6 race/ethnic populations (white, black, American Indian/Alaska Native (AI/AN), and Asian Pacific Islander (API) race groups and Hispanic/Latino and non-Hispanic ethnic groups regardless of race), by sex, for all sites combined and the 15 most common cancers were based on 73% of the U.S. population. Data for AI/ AN are not presented, despite recent linkages of registry data with the Indian Health Service patient database to improve identification, because the linkage variable was not available at the time of analysis. Averageannual (covering the 5-year period with the sum of all annual cases divided by the total annual population estimates for the same time interval) (1999) (2000) (2001) (2002) (2003) , sexspecific, and age-adjusted incidence rates were based on incidence data from 38 cancer registries, covering about 82% of the U.S. population, including 90% of the U.S. Latinos. All registries included in the analyses met NAACCR's standard for high quality cancer incidence data. Analyses on stage of disease excluded data from Maryland because of incomplete data, and analyses on county measures excluded data from Hawaii because a county identifier was not available on the file. Table 1 summarizes the descriptions of the cancer incidence data sets used for the various analyses.
Cancer incidence and death information is not shown for specific API and Hispanic/Latino groups because identifiers for these groups are not universally complete on reports of cases and deaths and intercensal county population estimates are not available from the U.S. Census Bureau.
Risk Factors and Screening
Data on socioeconomic status (SES), behavioral risk factors, and cancer screening by race, ethnicity, and Mexican, Puerto Rican, and Cuban groups, were obtained from the U.S. Census Bureau and the 2003 National Health Interview Survey (NHIS), 22,23 categorized according to Healthy People 2010 objectives. (In the 2003 NHIS, $74% of eligible adults responded. Black and Hispanic/Latino persons were oversampled in the survey, and among Latinos, 63% self-identified as Mexican or Mexican American, 10% as Puerto Rican, 5% as Cuban or Cuban American, 3% as Dominican, 18% as another Hispanic descent, and 1% with multiple Hispanic origins.) 24 Cigarette smoking, physical activity, alcohol consumption, and Pap tests (women only) were asked of adults aged 18 years or older. Also asked were mammography among women aged 40 years or older, colorectal cancer screening among persons aged 50 years or older, and prostate specific antigen (PSA) testing among men aged 50 and older who reported no history of prostate cancer. Self-reported obesity prevalence was estimated among adults aged 20 years and older, as were measured obesity estimates 25 from the National Health and Nutrition Examination Survey. 26 To describe the variation in cancer incidence by a geographic area's socioeconomic climate, we used the percent of county residents who lived below the poverty level. [27] [28] [29] [30] [31] [32] County poverty rates are a composite economic characteristic of a geographic area, including a reflection of health care services. [28] [29] [30] [31] County-level poverty data for all races combined were categorized into 3 groups according to the percent of the county population below the poverty level in 1999: <10%, 10%-19%, and !20% (most economically disadvantaged). 27, 30 Cancer incidence rate variations between metropolitan (metro) and nonmetropolitan (nonmetro) counties were assessed using the 2003 Urban/Rural Continuum, 33 also consistent with the Office of Management and Budget metro categories. This U.S. schema includes 813 metro counties (continuum codes 0 through 3) and 2288 nonmetro counties (codes 4 through 9). 33 We examined the distribution of stage of disease at diagnosis for cancers of the breast, prostate, colon and rectum, lung, and cervix by county poverty groups. Cancer incident cases were staged using the 2000 SEER summary staging system. To eliminate the effect of a different staging system in use before 2001, only cases diagnosed from 2001 to 2003 were selected for cancer stage statistics. 34 
Hispanic/Latino Ethnicity Definition
Self-report provides the best and most direct approach to identify a person's race; however, this information is not always available on cancer records. NAACCR developed a standard approach to improve the identification of Latino ethnicity for cancer cases and it was used for this report. The NAACCR Hispanic/ Latino Identification Algorithm, version 2 (NHIA v2), includes both direct and indirect identification of Latino cases, resulting in all persons having an ethnicity assigned. The indirect component is a hierarchical algorithm of ethnicity assignment based on race, birthplace, gender, maiden name, and surname. 35 The terms Hispanic, Latino, or Latina, are used to refer to persons of Hispanic origin. The word Hispanic is a U.S. federal designation, used in national and state reporting systems. Latino/a is a self-designated term of ethnicity. To be parsimonious in the text and tables, the terms Latino, Hispanic, non-Hispanic white (NHW), and non-Hispanic black (NHB) are used without preference or prejudice.
Statistical Analysis
Cancer incidence and death rates are expressed for 1999-2003 per 100,000 persons and age-adjusted by 19 age groups (<1, 1-4, 5-9, . . . , 80-84, 85þ ) to the 2000 U.S. standard population. 13, 36 (The NCHS publishes age-adjusted death rates using the established federal methodology based on 11 age groups, typically in 10-year age categories [<1, 1-4, 5-14, 15-24, . . . , 65-74, 75-84, 85þ ] and weights from the 2000 population projections. 36 The number of age groups [e.g., single-year, 5-year, or 10-year] used for age adjustment may affect estimated rates slightly. 21 ) Cancer incidence rates for 0-19 year olds are expressed per million persons and age-adjusted within the same age categories noted earlier. Age-adjustment eliminates the age effect on statistics, facilitating comparisons of other variables of interest (e.g., ethnicity). Rates, standard errors, 37 and 95% confidence intervals (95% CI) were generated using SEER*Stat Software (www.seer.cancer.gov/seerstat/).
Long-term cancer incidence and death trends (1975 through 2003) are described using joinpoint analysis for all races combined. 38 Statistical significance was set at P < .05. We present the observed incidence trends and those adjusted for reporting delay (mostly affecting recent years) using models based on long-term reporting patterns in SEER. 39 Descriptions of long-term cancer incidence trends are based on the delay-adjusted rates. Annual percent change analysis (not delay-adjusted) was used to describe fixed interval trends (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) . For all trends, the term increase or decrease (negative sign) was used when the slope of the trend was statistically significant; otherwise, the term stable or level was used.
Prevalence estimates for screening and risk factors were calculated using data from the 2003 NHIS sample adult file and age-adjusted to the 2000 U.S. standard population and sample-weighted using SUDAAN software to account for the complex NHIS sampling design. 40, 41 This followed standard procedures for analyzing NHIS data. (A table of 95% CI is available at: www.seer.cancer.gov/report_to_nation/1975_2003/). Data were suppressed when cell counts were less than 50 persons following NHIS rules.
Incidence rate comparisons by county poverty, metro area, and disease stage among Hispanic, NHW, and NHB populations are shown by rate ratios (RR), with Hispanics/Latinos compared with NHW and NHB groups. A 95% CI is presented for RRs to show precision, in addition to stating statistical significance (P < .05) of comparisons. In describing all comparisons, the terms higher (more likely) or lower (less likely) were used when the difference in the rates was statistically significant (P <.05). Otherwise, the RRs were described as comparable. Thus, when the RR was less than 1.0, the rate among Latinos was lower, and if greater than 1.0 the rate was higher, than the comparison group.
Since population estimates for specific Latino population groups are not available from the US Bureau of the Census by age and sex for all years (1999) (2000) (2001) (2002) (2003) , the proportional incidence ratio (PIR) was used to compare the proportion of all cancer cases due to a specific cancer type among a specific Latino group with the corresponding proportion among NHW persons. The PIR uses age-adjustment analogous to indirect age standardization whereby the proportions are dependent on other cancer types. The 95% CI is presented to reflect the precision of the PIR estimate. 42 More information related to this report is available at the NCI Web site www.seer.cancer.gov/report_ to_nation/1975_2003/. Additional cancer data are available from www.cancer.org (ACS); www.cdc.gov/ , and cancers of the pancreas and brain and other nervous system [brain]). Cancer of the larynx, on the top 15 sites for males in previous years, was replaced by myeloma in this year's ranking.
Among women, the rates for NHL, melanoma, leukemia, and cancers of the lung, bladder, and kidney have been increasing for 28 years. The cancer incidence rates decreased during the most recent segment for cancers of the colon and rectum, corpus and uterus NOS (uterine corpus), ovary, and oral cavity, while stomach and cervix uteri (cervix) cancers have declined since 1975. The incidence rates for breast cancer stabilized from 2001 through 2003, ending increases begun in the 1980s. The incidence rates for pancreatic cancer also stabilized from 2000 through 2003, after decreasing for 16 years.
In women, thyroid cancer incidence rates have increased since 1981; the rate of increase doubling in 1993; and in 2000, doubling again to 9.1% annually through 2003. The long-term rates increased in all age groups in both men and women, although the most dramatic increase in men occurred since 1996 among (Table 3 ).
In the most recent joinpoint segment, death rates decreased for 11 of the 15 most common cancers in men (i.e., lung, prostate, colon and rectum, pancreas, leuke- Among men, the top 3 incident cancers from 1999 through 2003 continued to be cancers of the prostate, lung, and colon and rectum in all race/ethnic populations (Table 4 ). Bladder cancer and NHL were the fourth and fifth most common cancers in most race/ ethnic populations, with the exception of black and API men. Cancers of the kidney and bladder were the fourth and fifth most common sites in black men, and in API men, they were cancers of the liver and stomach. Incidence rates declined from 1995 through 2003 for cancers of the lung, stomach, oral cavity, and larynx and increased for thyroid cancer in all race/ ethnic populations examined. Incidence rates of kidney and liver cancers increased in all race/ethnic populations except API. Colon and rectum cancer incidence rates declined in white and non-Hispanic (all races) men, but not in others. NHL incidence rates declined in all race/ethnic populations, except non-Hispanic and API. Incidence rates were stable for cancers of the prostate and bladder in all race/ethnic populations. Three of the top 15 common cancers had different 1995-2003 trends among the race/ethnic groups. Pancreatic cancer incidence rates increased in white and non-Hispanic men, but decreased in black men; esophageal cancer incidence rates decreased in Latino (all races), black, and API, but increased in white and non-Hispanic, men. Melanoma increased in non-Hispanic and white men, but decreased in black men. Among women, cancers of the breast, colon and rectum, lung, and uterine corpus continued to be the top 4 incident cancers from 1999 through 2003 in all race/ethnic populations, although the rank order of the top 3 cancers varied ( Table 4 ). The fifth most common cancer was NHL in women of all races and ethnicities, except black and API women. The fifth most common cancer was pancreas in black, and thyroid in API, women. Cervical cancer was the only cancer among the top 15 cancers that decreased in women of all races and ethnicities, while cancers of the kidney and thyroid were the only cancers that increased in all female populations. Lung cancer incidence rates continued to increase from 1995 through 2003 in non-Hispanic (all races) and white women, but not in women of other races or ethnicity. Incidence rates were stable for cancers of the breast and colon and rectum in all race/ethnic populations, except colon and rectal cancer in white women, for which the rates declined from 1995 through 2003. Melanoma increased in non-Hispanic, white, and API women. Incidence rates of NHL increased in non-Hispanic and black women, but not in others. Ovarian cancer incidence rates declined in women of most races and ethnicity, except black and API women. Stomach cancer incidence rates decreased in women of all races and ethnicities, except Latinas.
The fixed-interval incidence trends from 1995 to 2003 showed more sex than racial/ethnic differences. The trends in more of the top 15 cancer sites in men were decreasing for each population group than among the top 15 cancer sites in women.
Among men, the 3 leading causes of cancer death from 1999 to 2003 continued to be cancers of the lung, prostate, and colon and rectum in most race/ethnic populations (Table 5) , except API males, in whom they were lung, liver, and colon and rectum. Trends in death rates declined from 1995 through 2003 for cancers of the lung, prostate, and colon and rectum in all race/ ethnic populations, except API and AI/AN, in whom death rates were stable for cancer of the colon and rectum. Death trends for cancers other than the 3 leading cancers varied by racial/ethnic population. Death rates of liver cancer increased from 1995 through 2003 in Latino, non-Latino, and white men and were stable in black, API, and AI/AN men. Death rates of esophageal cancer declined in Hispanic and black men, increased in non-Hispanic and white men, and were stable in API and AI/AN men. Death rates declined from 1995 through 2003 in 11 of 16 cancers in non-Latinos and 9 of 16 cancers in Latinos. Differences were observed for cancers of the bladder and brain, leukemia, and myeloma, where rates in Latinos were stable; melanoma, where rates in Latinos decreased; and esophageal cancer where rates in Latinos decreased and those in white men increased.
Among women, cancers of the breast, lung, and colon and rectum continued to be the 3 leading causes of cancer death from 1999 to 2003 in all racial and ethnic populations, although the rank of the second and third cancers varied ( Table 5) . Compared with men, Compared with non-Latinos, Latinos are more likely to speak a language other than English at home and to reside in a metropolitan area. Latinos are less likely than non-Latinos to have health care coverage, especially when they are younger than 65 years. Hispanic persons are much less likely to have a regular source of medical care than are non-Hispanic populations, with Latino men being the least likely.
Risk/Prevention/Early Detection
Cuban men and women had similar smoking rates and were more likely than any of the other Latino groups to smoke ( Table 6) ; Puerto Rican and Mexican women were the least likely. Cuban men were the least likely to be obese and Puerto Rican women were more likely, based on self-report, to be obese than all other gender-race/ethnic groups, except NHB women. Cuban women were less likely to have leisure time physical activity while this characteristic for Puerto Rican and Mexican women was similar to NHB women. Reporting at least 1 day in the last year when 5 or more alcoholic drinks were consumed was more common among men than women, and among males, it was less common among Cubans.
The 3 major Latino population groups were less likely to have either a fecal occult blood test or an endoscopy than were NHW or NHB groups. Pap testing and mammography screening were comparable among all Latinas, but only Pap tests occurred less in Latinas than in NHW and NHB women. Latino men were less likely than NHW men to have had a PSA test in the last year.
Cancer Incidence
Latinos had lower incidence rates than NHW or NHB populations for the majority of specific cancer sites, including lung, colon and rectum, breast, and prostate cancers ( Table 7 ). Incidence rates that were higher in Latinos than in NHW populations included cancers of the stomach and liver in both males and females and myeloma and cervical cancer in Latinas. Cancer of the liver had more than a 2-fold incidence in Latinos than in NHW persons. Incidence rates that were higher in Latinos than in NHB populations were cancers of the liver and brain, NHL, and melanoma regardless of gender; cancers of the bladder and testis in Latino men; and leukemias and cancers of the cervix, ovary, and thyroid in Latinas.
In addition to the cancer sites in Table 7 , Latino men and women had lower rates than NHW men and women for cancers of the small intestine, soft tissue and heart, anus, and eye and orbit. (A data table of statistical test results and 95% CI is available at: www. rates than did NHB populations for mesothelioma; ALL; and cancers of the gallbladder, bones and joint, ureter, and eye and orbit. Latino men also had higher rates of cancer of the penis than did NHB men and Latinas had higher rates of ALL than did NHB women. Dissimilar to all other smoking-related sites, Latino men and women had higher rates of lip cancer than did NHB men and women.
Site-Specific Rates by Age
The 
Cancer in Latino Children and Adolescents
Incidence rates for all cancers combined were lower among Latino than NHW boys (aged 0-14) and Latino adolescents of each sex (aged [15] [16] [17] [18] [19] , but rates were higher among Latinos than all NHB children and adolescents (Table 8) . Cancer-specific rates among Latino children and adolescents were generally similar or higher than those of NHB groups (with the exception of renal tumors in all Latino children and soft tissue sarcomas in male adolescents), and thus comparisons that follow are limited to Latino and NHW children and adolescents. Of the 12 major cancer groups, Latino boys had lower incidence rates for CNS tumors, neuroblastoma and other peripheral nervous cell tumors (neuroblastomas), renal tumors, and other malignant epithelial neoplasms and melanomas (epithelial neoplasms) and higher incidence rates, than did NHW boys, for leukemias, retinoblastoma, and germ-cell tumors. Incidence rates for Hodgkin lymphomas and osteosarcomas were also higher among Latino than NHW boys, although the combined rates for all lymphomas and reticuloendothelial neoplasms (lymphomas) and for all malignant bone tumors (bone tumors) were not different. The difference in leukemias incidence rates between Latino and NHW adolescents was greater than it was between children of the 2 groups. For osteosarcomas and germ-cell tumors, the differences observed in Latino, compared with NHW children, disappeared in adolescents. In contrast to these patterns, incidence rates for Hodgkin lymphomas were similar among Latino and NHW boys, but lower among Latino, than NHW male, adolescents.
Latina girls, aged 0-14 years, had lower incidence rates of CNS tumors, neuroblastomas, renal tumors, and epithelial neoplasms and higher incidence rates than did NHW girls for leukemias, retinoblastoma, and germ-cell tumors. Incidence rates of osteosarcomas were higher among Latina than NHW girls, although the rate of all bone tumors was similar. The difference in incidence rates between Latinas and NHW female adolescents disappeared for osteosarcomas, but remained for leukemias and germ-cell tumors.
County Poverty and Cancer Incidence
As county poverty increased, the cancer incidence rates of liver (including hepatocellular carcinoma in both men and women) and cervix (women) increased in Latinos, a pattern similar to other race/ethnic groups (Table 9 ). Cancer incidence rates of the prostate, breast (female), bladder (men and women), and uterine corpus (excluding NHB women) in all race/ethnic groups were highest in counties with less than 10% poverty. The RRs of the higher poverty compared with <10% poverty counties were lower for cancers of the colon and rectum and bladder among Latinos and Latinas and breast (Latina) than in the other 2 race/ethnic groups.
Cancer Among Latino Population Groups
After age-adjustment, the proportion of liver cancer was higher among all Latino groups when each was compared with NHW persons ( Table 10) ; cancers of the stomach and gallbladder were proportionally higher among all groups when each was compared with the NHW population (except stomach cancer in Cuban males and gallbladder cancer in Cuban females). Prostate cancer was proportionally higher in Cubans and South/Central Americans than in NHW men, and lower in Mexicans than in NHW men. Kidney cancer was higher in Mexicans of both sexes and lower in the other specific Latino groups when compared with NHW men and women. Conversely, breast cancer in each Latina group was proportionally lower than in NHW women, as was lung cancer for both Latino men and women.
Stage of Disease at Diagnosis
Latinos were less likely to be diagnosed with localized disease (among selected cancers, i.e. breast, cervix, prostate, lung, and colon and rectum) than were NHW, and about the same as NHB men (Table 11) . Latinas, however, were the least likely to be diagnosed with cervical cancer in a distant stage, while all Latinos were the most likely to be diagnosed with lung cancer in a distant stage. NHW persons had the highest proportion of cases diagnosed in a localized stage for all 5 cancer sites. The proportion of the cancers of regional and distant stage combined was similar across county poverty levels, except breast and cervical cancer among Latinas, where the combined percent of regional and distant stages increased with increasing county poverty. Compared with NHW men and women, Latinos were more likely to be diagnosed in the combined group of regional and distant stages within each of the county poverty levels, although NHB women had the highest proportion of cases diagnosed at a distant stage among the 3 racial and ethnic groups. Regardless of ethnicity or race, the proportion of cases diagnosed with an unknown stage for the selected common cancer sites increased as the county poverty level increased. Latino cases residing in counties of <10% poverty had the lowest proportions of unstaged cases among the 3 populations, but in 20%þ poverty counties, the proportion of unstaged cases exceeded that of NHW and NHB persons (e.g., cancers of the colon and rectum, prostate, and breast).
Metropolitan and Nonmetropolitan Areas
The RRs between age-adjusted incidence rates were higher in metropolitan than in nonmetropolitan counties among the Latino, NHW, and NHB race/ethnic groups for cancers of the bladder, colon and rectum, liver, and stomach for both men and women, and higher for prostate cancer. (A data table is available at: www.seer.gov/report_to_nation/1975_2003/). Lung cancer rates were lower for metro NHW and NHB males, but not in Latino males; while in females, the nonmetro Latina lung cancer rates were higher than those of metro Latinas, opposite of the pattern observed for NHW and NHB women. For cancers of the uterine corpus, cervix, and breast, the metro/nonmetro gradient was not observed for Latinas, while the metro rates were higher than nonmetro rates for the other 2 race/ethnic female populations. Rate ratios for gallbladder cancer did not suggest a metro/ nonmetro gradient for any race/ethnic group.
DISCUSSION
The overall decline in cancer death rates, first noticed in the early 1990s, 1 has continued through 2003. In addition, many cancer sites have declining death and incidence rates. These are attributable in part to successful cancer prevention efforts to reduce exposure to tobacco and other cancer risk factors, earlier detection of disease through screening, improved prognosis through more effective treatment, and reduction in inequalities in cancer care through more widespread access to effective diagnostic and treatment regimens by the general population. These all point to the success of the nation's dedication and focus on reducing the burden of cancer in the U.S. Continued success will depend on maintaining and enhancing these efforts. 45 Overall Cancer Incidence and Mortality Trends in the United States Some site-specific trends are more variable, affecting annual interpretation of incidence statistics. The join-point regression model suggests a small increase in the female lung cancer incidence rate from 1991 through 2003, a change from previous estimates, 7, 8 where rates from 1998 through 2002 appeared stable. 8 Using the fixed-interval (1995-2003) lung cancer trend to compare age-specific trends, rates were increasing in women for all age groups 65 years and older, decreasing among women aged 45-64 years, and stable in women younger than 45 years. In men, however, lung cancer rates were decreasing in all age groups. Women in the oldest cohort, with the highest proportion of long-term smokers, will continue to have the greatest impact on the trends, until the younger cohorts move into the age groups of highest lung cancer incidence. 46, 47 This year the previously reported increase 8 in breast cancer incidence rates stabilized. Most regis- tries in the SEER regions, upon which the long-term trends statistics are based, reported a steep decline in the number of 2003 breast cancer cases; rates were lower in all but 2 of the 30 states included in the 1995-2003 fixed-interval trend statistics (data not shown). The factors that influence breast cancer incidence are complex, including changes in reproductive risks, obesity, age-cohort effects, and the prevalence of mammography screening, among others. Recent reports hypothesize about the impact of the rapid discontinuation of hormone replacement therapy (HRT) on breast cancer incidence. 48, 49 HRT is a known risk factor for breast cancer. 48, 49 Change, even stabilization, in mammography screening prevalence also affects incidence trends. 48 Whether this first indication of a changing trend is real or a random fluctuation cannot be determined until data reporting in the next few years is complete.
The fixed interval incidence trend of thyroid cancer has increased in both men and women, with longterm increases in women doubling twice in the last 10 years. Increases are observed in all U.S. racial and ethnic populations and all age groups, as well as globally. [50] [51] [52] [53] [54] Although not in the top 15 causes of death, long-term thyroid cancer death rate trends decreased in men from 1975 to 1983 and in women from 1975 to 1988. They have increased in men from 1983 through 2003 and have been stable in women from 1988 to 2003. 13 Changes in diagnostic procedures, including the introduction and greater use of ultrasonography and fine-needle aspiration biopsy, likely contribute to the incidence increase. 50, 51, 55, 56 Radiation exposure in childhood and adolescence is also a recognized risk factor. 57, 58 More research on the relation among temporal trends, diagnostic procedures, and exposure to radiation and other potential risk factors is needed. Incidence rates of kidney cancer have steadily increased for 28 years in both men and women. However, death rates from kidney cancer stabilized in men and declined in women over the last decade. Trends in stage-specific incidence rates of kidney cancer suggest that increasing detection of presymptomatic tumors by ultrasonography, computer tomography, and magnetic resonance imaging procedures is affecting the trends. However, it does not fully explain the steady increases. 59 Other factors such as smoking, obesity, and hypertension may also be contributing. 60 Incidence rates of leukemia steadily increased since 1975 in both men and women, while death rates declined since 1975 in men and 1980 in women. A study using SEER data from 1973 to 1998 suggested that leukemia incidence decreased among persons aged 65 years and older, but increased among persons younger than 20 years. 61 The trends also varied by subtype of leukemia. 61 The decline in leukemia death rates can indicate improvements in leukemia treatment.
Melanoma incidence in women continued the increase begun in 1975, but stabilized in men from 2001 to 2003. The fixed interval trends (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) increased in both white and non-Hispanic men and women and API women. Melanoma case reporting is challenging because diagnosis and treatment often occur outside the hospital-based cancer-reporting infrastructure. Although identification of cases has improved, the number of cases is most likely still underestimated. 39, 62, 63 Although long-term increases in melanoma incidence are influenced by early detection and improved case reporting, increasing trends are not confined to early stage tumors and may also be influenced by historical changes in sun exposure. 63 The statistics for cervical cancer are remarkable, in that both incidence and mortality rates have been decreasing for all race/ethnic groups since 1975. Although the data for specific race and ethnic groups are not available back to the 1970s, the fixed-interval rates since 1995 show that both incidence and death rates are declining in white, black, API, Hispanic, and non-Hispanic women. The improvements in screening have had a measurable impact on this disease. 64, 65 Despite these accomplishments, disparities in the trends by socioeconomic strata prevail. 66 
Cancer in Latinos
This report is based on 90% of the U.S. Latino population, the most comprehensive coverage of cancer information for this large and rapidly growing ethnic group. Although incidence rates for Latinos of specific origins could not be calculated, the data on screening and known cancer risk factors among specific Latino groups suggest several general points: first, not all His-panic populations in the U.S. are alike; 67 second, data reported from various studies on Hispanic populations may not be comparable if the underlying Hispanic populations do not share the same origins, cultural traditions, and immigration status; [68] [69] [70] [71] [72] and third, collection of specific Hispanic origin needs to be increased in general population and demographic statistics as well as in the records of persons diagnosed and dying from cancer. 68, 73 The cancer incidence data reported here on 90% of U.S. Latinos mirror findings of many other studies on various Latino groups or areas, 45, 68, 71, [74] [75] [76] [77] [78] [79] [80] [81] with a few exceptions. Rate estimates (Trapido et al. reported higher rates of cancers of the oral cavity and thyroid in white Latinas 81 and lower rates of stomach cancer in white Latinos, 80 compared with white non-Hispanic women and men, respectively), rank order of top cancer sites (Trapido et al. 79 reported for the U.S. that the top 5 cancer sites for Latinos were prostate, lung, colon, stomach, and rectum and for Latinas, cancers of the breast, colon, lung, cervix, and uterine corpus. Canto and Chu 68 found stomach cancer to be in the top 5 for both genders; we report bladder cancer in males and NHLs in females in the top 5 and not stomach cancer in either gender) and trends varied (both Cress et al. 75 and Eidson et al. 82 reported time trends for years that primarily preceded the 1995-2003 period reported in this article). Some differences may be attributed to variation in time periods under study, 68, 75, 79, 81, 82 the specific geographies and thus varying origins of the local Hispanic population, 67, 72 or limited statistical power to detect differences. 71, 83 U.S. Latinos have lower rates of several cancers that are higher in affluent, industrialized countries where tobacco use, obesity, and physical inactivity may be more prevalent. Several cancer sites with higher incidence rates in Latinos have infectious etiologies: human papilloma virus (HPV) in cervical cancer, Helicobacter pylori (H. pylori) in stomach cancer, 84 and Hepatitis B virus (HBV) and Hepatitis C virus (HCV) in liver cancer (and hepatocellular carcinoma). [85] [86] [87] [88] Explanations vary by site and may include higher prevalence or different age patterns of infection in the countries of origin (HPV), chronic infection (HBV and HCV), poor sanitary conditions (H. pylori), or varied availability and use of preventive measures. 89 Further, relative to the NHW populations, the proportion of new site-specific cancer cases, in relation to all cancer cases, varied among 4 Latino groups, suggesting that risks may be different for Latinos of different origin and that cancer risks may not be generalizable from one Latino group to another based on Hispanic ethnicity alone, as found in a comparison of age-adjusted mortality rates among foreign-born Latino groups in New York City. 67 
Children and Adolescents
The incidence of specific cancers differed substantially among Latino and non-Latino children and adolescents. Incidence rates for leukemia, retinoblastoma, and germ-cell tumors were higher among Latinos and rates for CNS tumors, neuroblastoma, renal tumors, and epithelial tumors were generally lower. Latino boys had a higher incidence rate of Hodgkin lymphoma than did non-Latino boys while all Latino adolescents had lower incidence rates than did NHW adolescents. Latino boys and girls had higher incidence rates of germ-cell tumors than did NHW children, an observation also seen for Latinos and NHW female adolescents. These findings are consistent with those of other studies. [90] [91] [92] The incidence of ALL is generally high in economically developed countries and low in developing countries; however, the highest rates in the world are reported in Costa Rica and among Latinos in Los Angeles, 93 although geographic variations in incidence are unexplained. Variation in possible etiologic factors for childhood leukemias, such as paternal smoking, occupational exposure to benzene, household solvents, home use of pesticides, radiation, maternal diet, child's diet, infection, and genetic susceptibility have been investigated with inconsistent results. 85, [94] [95] [96] [97] For Hodgkin lymphoma, incidence is low in children and high in adolescents and young adults in developed countries, while in developing countries, rates are high in childhood, then low until old age. 93 Age-related differences in histological subtypes have been observed. 98 Children with Hodgkin lymphoma are more likely to be positive for Epstein-Barr virus (EBV) than are adolescent and young adult patients. 99 Hodgkin lymphoma among adolescents and young adults may result from a delayed reaction to a common infectious exposure (not EBV) late in adolescence. 100 Higher incidence rates among Latino children and adolescents, than their NHW counterparts, were also observed for retinoblastoma, germ-cell tumors, and osteosarcoma. Incidence rates of retinoblastoma in Central and South America are somewhat higher than rates in North America and Europe. 93 Approximately 40% of children with retinoblastoma have a heritable gene mutation. Increased risk for retinoblastoma and osteosarcoma includes treatment with ionizing radiation or alkylating agents, Paget disease, hereditary retinoblastoma, and Li-Fraumeni syndrome. Germ-cell tumors and osteosarcoma are heterogeneous in histology, site, and behavior, and show relatively little variation internationally. 93 Among the cancers that have lower incidence in Latino children and adolescents, CNS tumors, neuroblastoma, and renal tumors have lower incidence rates in Central and South America than in North America. 93 Many questions are unanswered regarding cancer etiology in children and adolescents, exposure differences, and genetic predisposition between Latinos and non-Latinos. The diversity and large numbers of Latino immigrants to the U.S. provide a unique opportunity to study childhood and adolescent cancers.
Cancer Risk Factors
The county poverty rate can be a useful indicator of the availability and accessibility to health services. Access to state-of-the-art, quality cancer care is known to be unequal and to exacerbate existing disparities in cancer outcomes. [101] [102] [103] [104] [105] The variation in incidence rates for cancers of the prostate and breast may be partly related to different rates of screening for these diseases in counties with more poverty, 106 and the higher incidence rates of cancers of the liver, stomach, and cervix may be related to higher infection rates in populations of counties with more poverty. When available, examination of small geographic areas, such as census tracts with greater population homogeneity, could be useful. 28, 30, 31 For an earlier time period, 1988-1992 in San Francisco Bay, Krieger and colleagues 83 used census block group statistics to measure economic environment and found that breast cancer incidence increased with increasing area affluence only for Latinas, unlike the gradient reported here which was observed for all race/ethnic groups. Cervical cancer incidence increased for all women with increasing area deprivation, as did cancers of the prostate and colorectum in both men and women. 83 Unlike county poverty rates, metropolitan disparities were fairly similar among all 3 race/ethnic populations, suggesting that shared etiologies, a differential mix of Hispanic groups in metro/nonmetro areas, or perhaps, the imprecision of some estimates for Hispanics may be more influential factors. This is in contrast to a report from Texas, that did not find an urban/rural gradient, particularly among Latinas; 107 however, it was based on regional data from the early 1980s and a different classification for metro/nonmetro areas.
Overall, Latino men and women were more likely to be diagnosed with regional/distant disease than were NHW men and women, consistent with other reports. 69, 76, [108] [109] [110] Similar to data presented here, research demonstrates that Latina women are underscreened and the extent of underscreening varies by specific ethnicity and U.S. region of residence. [111] [112] [113] [114] [115] [116] [117] [118] Results vary of studies examining reasons for lower screening rates among Latinas. In New York City and California, when sociodemographic factors were controlled, the effect of ethnicity disappeared. 111, 119 However, Northern California Latinos with no direct financial barrier were still less likely than NHW persons to obtain screening for breast, colorectal, and cervical cancers. 120 In New York City, the extent of acculturation had a positive linear association with breast cancer screening. 113 Among Mexican Latinas in Texas, socioeconomic status (SES) and acculturation were not related to screening behaviors. 121, 122 Zambrana et al. 118 concluded from their analysis of NHIS data that access factors and screening history were more important than language and ethnic factors, as did Selvin and Brett. 123 Talavera et al. 124 found, from a survey of Latinos in 8 U.S. cities, that access to a healthcare plan/insurance predicted digital rectal screening for colorectal and prostate cancer for Mexican and Central American Latinos and English language use was a predictor for Mexicans and Cubans, but not Puerto Ricans. They posit that the differences may be associated with the local availability of Spanish-speaking health practitioners. Among a rural Hispanic population in Washington, mostly originating from Mexico, support was mixed for the association of SES and cancer screening. 125 Compared with NHW persons, breast and colorectal screening differences disappeared after controlling for SES, and yet differences in cervical cancer screening and smoking behavior persisted. 125 In the study area, sliding fee health services were available for all low income persons and yet, regardless of ethnicity, the authors suggested that access barriers, such as long wait-times at the clinic, may dissuade persons to avail themselves of screening. 125 
Latino Outreach and Community Programs
Health disparities among U.S. populations are a focus for increased research and interventions. Redes En Acción, the National Latino Cancer Research Network is in the vanguard of U.S. programs seeking to bridge cancer disparity issues in Latinos. 126, 127 As one of the NCI's Community Networks Programs, Redes En Acción represents a strong effort to coalesce a broad range of forces-NCI cancer centers, academic institutions, governmental entities, national organizations and foundations, and community-based groups-to address diverse Latino cancer issues. While scientific endeavor is paramount, Redes En Acción recognizes that the challenges cannot be met by research alone. Through collaboration, the initiative applies a translational approach, establishing pipelines from national entities through regional and local groups to the public, and confronts issues through a combined research, professional training, and public education continuum. 127 Accomplishing the mission of these networks relies on accurate and timely data to elucidate differences in risk factors, site-specific incidence and mortality, and stage-specific data, potentially related to differences in access to timely cancer diagnosis and care. Similar to other groups, lung cancer is the leading cause of cancer death among Latinos; hence smoking prevention and cessation efforts are vital in reducing this and other tobacco-associated cancers. Important considerations in developing health interventions, including comprehensive cancer control, outreach, and care for Latinos, are higher incidence of some infection-related cancers in adults; elevated exposures to environmental risk factors in Latino living and work places; lower education, health literacy, and income; limited English proficiency; reduced use of screening services; poorer access to health care often due to no insurance; and less information available regarding possible genetic predispositions. 70, 102, 114 Also, this population experiences unique cultural and language barriers to health services, in addition to the multitude of institutional, environmental, logistical, sociodemographic and personal barriers characteristic of all U.S. minority groups. 101, 127 The Cancer Prevention and Control Research Network (CPCRN) is a national network of academic, public health, and community partnerships recently established to accelerate the adoption of evidence-based cancer prevention and control in communities, particularly those evaluated by the Community Guide. 128 The Network is engaged in research and practice activities that span the translation continuum from discovery to the dissemination and adoption of effective interventions. In particular, the Network engages in large-scale efforts to reach underserved populations. The Latinos in a Network for Cancer Control is one of the CPCRN sites whose purpose is to maintain and further develop a Cancer Prevention and Control Network for Texas and surrounding states along the U.S.-Mexico Border. The network collaborators are broad-based and include a CDC Prevention Research Center at the University of Texas School of Public Health, community-based organizations such as the National Center for Farmworker Health; health departments, practice settings, Redes En Acción, and the NCI-supported cancer research center at M.D. Anderson. The Racial and Ethnic Approaches to Community Health (REACH) initiative is another important federal initiative that supports community coalitions in designing, implementing, and evaluating community driven strategies to eliminate disparities experienced by Latinos and other minority populations. 129 Several examples of other national networks for community programs include the National Breast and Cervical Cancer Early Detection Program. 130, 131 The Guide to Community Preventive Services evaluates research on the effectiveness of community interventions to reduce cancer risk factors and increase screening and makes recommendations about effective interventions, 128 including their effectiveness in low income and minority populations.
Despite limited progress in recent years, according to the 2005 DHHS National Health Disparities Report, health disparities between Latino and NHW populations have generally increased. 132 The Redes En Acción Latino Cancer Report emphasizes the continued need to improve access to cancer screening and care, reduce tobacco use, improve communication of cancer risk, expand research on cancers linked to infections and cancer-related survivorship and quality of life, and enhance efforts to educate, train, and reach out to Latinos for cancer prevention and control. 126 Further, addressing Latino cancer issues requires research on disseminating effective treatments, educational programs to promote healthier lifestyles, and use of screening services; greater access to prompt and appropriate care; clarification of genetic susceptibilities and genetic-environmental interactions; and improved cultural competency among all cancer care givers, including physicians. 44, 69, 111, 113, 114, 118 Public health interventions that may reduce infection-related cancers among U.S. Hispanic populations include immunization against Hepatitis B and the most common oncogenic strains of HPV, screening and counseling for Hepatitis B and C, and screening for cervical cancer. 89 In addition, despite the existence of strong cultural protective factors, cancer-related health disparities affecting Latinos will continue to worsen if the social and economic disparities noted earlier are not also addressed.
Issues in Data Interpretation
The data reflect a substantial proportion of the U.S. population in general, and each of the race/ethnic groups in particular. It is an achievement that beginning with 1995, cancer rates can now be generated by site and sex for most of the U.S. population stratified by ethnicity and 3 major race groups. The cancer incidence surveillance infrastructure has reached a major benchmark: high quality data that can be used for crosssectional rates and short-term, fixed interval trends.
Some limitations may influence interpretations of the data. Direct and even self-identification of ethnicity is preferred, yet still inconsistent and under-reported on medical records and death certificates. [133] [134] [135] [136] [137] [138] Indirect methods to enhance this information have been employed by cancer registries in the past, but with great regional variation in definition and application. 35, 139 Efforts are in progress to improve the completeness of self-identification in medical records, but until that is achieved, all cancer registries can now use a standard method to enhance identification through NHIA v2, a method that enhances direct identification with indirect measures. 35 The agencies involved in this report are also working to improve the identification of AI/AN and API cancer cases in cancer registries.
Cancer statistics are commonly reported according to the major racial and ethnic populations-white, black, API, AI/AN, and Hispanic/Latino. As suggested by statistics for Latinos here and by others, 140 broad racial and ethnic groupings may mask wide variations in the cancer burden for specific API, 141, 142 AI/AN, black, or even white, persons, and by cultural characteristics that define high risk populations such as urbanicity, economic deprivation (both personal and area-based), or recent immigration. 101, [143] [144] [145] A PIR, although not a measure of risk, is the best available measure to look at data for specific Latino and other groups when neither annual population estimates nor specific Latino group identification in medical records are available to compute age-standardized rates.
We used 2 different statistical methods to describe cancer trends. A joinpoint model was used to characterize long-term patterns for all races combined. A simple linear model was used to describe trends for a fixed time period to facilitate comparisons in cancer incidence and death rates by race/ethnicity, sex, and cancer sites. In some circumstances, these approaches may yield different information, leading to different, even conflicting, interpretations due to the nature of trends summarized by the 2 models and to the different geographic coverage to which each was applied. The joinpoint method is more flexible and accurate in identifying the years in which there were significant changes in trends. The long-term incidence trends are based on the SEER data covering 10% of the population for 1975-2003 (delay-adjusted), and in geographic areas that are more urban than the U.S. as a whole. Fixed-interval incidence trends for 1995-2003 are based on the data reported to NAACCR from SEER and NPCR registries, covering about 73% of the population for 1995-2003 (not delay-adjusted).
A county-based economic measure should not be used to impute individual economic achievement, being a function of both social and aggregated individual characteristics. Moreover, in large metropolitan U.S. counties, such as Los Angeles, Cook (Chicago), or New York (Manhattan), even a single county measure does not accurately reflect the wide variation of area economic characteristics within the county. Measures for smaller areas, such as Census block groups, would be preferable for inferring social or individual economic characteristics. 83, 105 However, identification of cancer cases by these small geographic areas is difficult to obtain in a multi-registry-aggregated data file because of concerns of patient privacy. Most NAACCR member registries are not yet comfortable, even if permitted by law, to release these small area identifiers. We expect that when permitted by law, these barriers will be overcome as both incidence and population estimates improve (minimizing misinterpretation of small area statistics) and researchers can assure patient privacy.
The percentage of unknown stage cases varied from 3% to 17% for different race and ethnicity, cancer site, and county poverty categories. The large variation in the percentage of unknown stage cases may bias comparisons of stage by race, ethnicity, or county poverty.
Finally, anecdotal reports that Hispanic immigrants return to their country of origin after a cancer diagnosis would cause an underestimate of deaths and potentially death rates. Generational changes in this practice could also impact death trends. Empirically assessing this phenomenon is difficult without complete follow-up of cancer patients migrating out of the country and without the ability to link on an individual level, information on foreign-born status from the U.S. Census and health, cancer, and death data.
Future Directions
The purpose of this report is to provide an overview of the most current information on the status of the cancer burden in the U.S. and to spotlight a cancer topic of interest. To produce the most comprehensive report, detailed explanations of any one aspect covered in the report are not feasible. Only reference to recent research or suggestions for future directions can be provided for the reader to gain a greater understanding. This was the first year that detailed cancer risk, early detection, and mortality information were featured with incidence data for 90% of U.S. Latinos. Description of cancer risks included not only traditional demographic variables but also urbanicity and economic environment. Our results raised many questions: How do the changing race/ethnic demographic characteristics of the U.S. affect declining trends? Can they be attributable, even in part, to rapid growth in the population of persons of lower cancer risk, like Latino populations? Or, What is driving the accelerated increase in trend for thyroid cancer in women, now that the radiation risk affecting older cohorts is no longer a common practice? Is there a new emerging risk or can it be explained by better medical surveillance of other conditions that lead to the observed increase? And also, If we improve cancer care through early diagnosis and tumor staging in high poverty areas, could we improve cancer prognosis and mortality in these areas, thereby eliminating this inequality? Given the general observation that adolescents and young adults have not realized comparable gains in survival and mortality as have children and older adults, 7 is there an additional disparity by race or ethnicity? These and other questions need to be addressed in special studies.
By 2050, the U.S. population will be older; only half will be white and the greatest growth will occur among Latino and Asian populations. 146 As these populations age and grow in size, they may influence the cancer types, prevention and diagnostic practices, and relative demand for stage-specific treatments and general access to timely care that will face this nation. Further, we expect that health care costs will continue to escalate. Awareness of these issues must stimulate action to eliminate known inequalities before they worsen and are further exacerbated by the aging of the population and inflationary health care costs. 101, 103, 104, [147] [148] [149] [150] The inequalities in cancer risk, incidence, and prognosis between Latino and non-Latino populations can be reduced by eliminating exposure to infectious agents that cause cancer; with acculturation in the U.S., preventing Latinos from adopting traditionally avoided high risk cancer behaviors; 71, 72, 74, [151] [152] [153] [154] increasing use of effective clinical prevention services; and assuring that every person diagnosed with cancer has affordable and timely access to state-of-the-art, quality cancer care. [102] [103] [104] 148 We need the continued support and leadership of all the organizations collaborating on this report and the interest of researchers and cancer control specialists throughout the country to focus on continued methodologic and classification improvements in surveillance approaches and to study the issues and determine effective intervention methods for diverse populations. 155, 156 Truly, the public, as well, must continue to insist that the highest priority be maintained to reduce the burden of cancer so that we all can continue to work effectively toward the elimination of inequalities in the burden of this disease among all persons in the U.S.
